VantageMed Announces Schedule For Third Quarter 2004 Earnings
Published: Nov 05, 2004
RANCHO CORDOVA, Calif., Nov. 4 /PRNewswire-FirstCall/ -- VantageMed Corporation (OTCBB: VMDC.OB) will issue a press release announcing its third quarter 2004 financial results after the close of the market on Monday, November 8, 2004.
The Company will also host a conference call to discuss financial results at 5:00 p.m. Eastern Time on the same day. The call will be broadcast live over the Internet and can be accessed at http://phx.corporate-ir.net/playerlink.zhtml?c=76749&s=wm&e=964472 or on the investor relations page located at http://www.vantagemed.com/. A replay of the call will be available for 90 days.
VantageMed is a provider of healthcare information systems and services distributed to over 12,000 customer sites through a national network of regional offices. Its suite of software products and services automates administrative, financial, clinical and management functions for physicians and other healthcare providers and provider organizations.
This press release may be deemed to contain "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements are made as of today's date and we do not undertake any obligation to update forward-looking statements. You can identify such statements by our use of such words as "should", "expect," "will," "intends," and similar words and phrases which denote future events and which may depend on the future performance of the Company. Our assumptions underlying these statements are also "forward-looking" statements. Forward- looking statements are based on information and assumptions that are dynamic in nature and subject to rapid and sometimes abrupt changes. Our forward- looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those stated or implied by the statements. These risks and uncertainties include risks related to our failure to improve our operating cash flow, the inability of our restructuring efforts to improve profitability and our inability to increase our revenue or to grow the sales of our products. Our forward-looking statements are also subject to important risks and uncertainties detailed in our latest reports filed with the SEC and available on its website at http://www.sec.gov/.VantageMed Corporation
CONTACT: INVESTOR RELATIONS: Liesel Loesch, +1-916-638-4744, ext. 213,or firstname.lastname@example.org, or MEDIA: Jennifer Morgano, +1-510-536-6012 email@example.com, both of VantageMed Corporation
Web site: http://www.vantagemed.com/